Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award No cap on assistance (unless otherwise specified) · Income Income-based eligibility; threshold not published · Copayments, coinsurance, deductibles, health insurance premiums, therapy administration costs, treatment-related ground travel
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
G61.81 G70.00 G70.01Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 855-530-2242, and check the alternatives below.
Manufacturer copay programs may also apply — see the drug pages: Vyvgart + Vyvgart Hytrulo.
Status shown as of each fund's last verification.
As of June 18, 2026, the The Assistance Fund Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) fund is operating a WAITLIST. Call the foundation to confirm current intake. Verify at time of service: 855-530-2242.
No cap on assistance (unless otherwise specified). Copayments, coinsurance, deductibles, health insurance premiums, therapy administration costs, treatment-related ground travel
Household income must be Income-based eligibility; threshold not published. U.S. resident.
Accepted: commercial, medicare, medicaid.